Coping Compliance and Adjustment in Adolescents With Cystic Fibrosis
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
In this research, we will use established surveys to look at the relationship between various styles of coping with a disease, religious coping styles, treatment compliance, locus of control, broad measures of mental health and adjustment, and basic health data (e.g., PFTs, recent hospitalizations or antibiotics within the past year, lung microbiology, CFTR mutations, and co-morbid conditions such as diabetes, depression, and liver disease). While the research is correlational, it should suggest relationships (both positive and negative) between various coping styles and desired outcomes (compliance and well-being).
| Condition |
|---|
|
Cystic Fibrosis |
| Study Type: | Observational |
| Study Design: | Observational Model: Cohort Time Perspective: Cross-Sectional |
| Official Title: | Coping Compliance and Adjustment in Adolescents With Cystic Fibrosis |
- Multiple measures of coping strategies in adolescents with cystic fibrosis. [ Time Frame: Single visit ] [ Designated as safety issue: No ]
- Coping startegies will be correlated with measures of clinical illness. [ Time Frame: Single visit ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 40 |
| Study Start Date: | October 2007 |
| Study Completion Date: | April 2008 |
| Groups/Cohorts |
|---|
|
1
Adolescents with CF.
|
Detailed Description:
OVERVIEW: We anticipate that the data we collect will help us better understand some of the factors associated with improved coping, treatment compliance, and emotional adjustment, which, in turn, may suggest possible interventions to improve compliance, emotional adjustment, and general physical health. Specific hypotheses include the following:
- Subjects who score high on measures of positive coping will have greater levels of treatment compliance and psychological well-being.
- Subjects who score high on measures of negative coping will have lower levels of treatment compliance and psychological well-being.
- Subjects who score high on measures of positive religious coping will have greater levels of treatment compliance and psychological well being.
- Subjects who score high on measures of negative religious coping will have lower levels of treatment compliance and psychological well-being.
- Subjects who score high on measures of internal locus of control will have higher levels of treatment compliance and psychological well-being compared to subjects who score low on measures of internal locus of control.
- Subjects who score high on measures of treatment compliance will have higher levels of physical health.
- We do not anticipate a positive correlation between positive coping mechanisms and general physical health; however, subjects who score high on measures of negative coping may have lower levels of general physical health (e.g., lower PFTs, increased rates and lengths of hospitalizations) probably due to third variables (e.g., if someone uses denial as a coping mechanism, it may lead to poor treatment compliance, which may lead to declines in physical health).
- Anecdotal evidence suggests that parental education may be positively correlated with treatment compliance, but this has not been evaluated. Likewise, anecdotal evidence suggest that marital status may be correlated with treatment compliance (probably because of third variables, e.g., if, as much research suggests, divorce is related to lower SES and fewer social supports, these factors may in turn interfere with treatment compliance). Two questions on the demographic sheet will allow us to explore whether or not this may be worth exploring further.
Eligibility| Ages Eligible for Study: | 13 Years to 19 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Adolescents age 13-19 with CF at a single CF center.
Inclusion Criteria:
- cystic fibrosis age 13-19 yrs
Exclusion Criteria:
- acutely ill
Contacts and Locations| United States, Ohio | |
| Akron Children's Hospital | |
| Akron, Ohio, United States, 44308 | |
| Principal Investigator: | Nathan C Kraynack, MD | Akron Children's Hospital |
More Information
No publications provided
| Responsible Party: | Nathan Kraynack, MD, Akron Children's Hospital |
| ClinicalTrials.gov Identifier: | NCT00577252 History of Changes |
| Other Study ID Numbers: | COPING1424, COPING1424 |
| Study First Received: | December 18, 2007 |
| Last Updated: | November 23, 2009 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by Akron Children's Hospital:
|
Cystic fibrosis Adolescents Coping Compliance Adjustment |
Additional relevant MeSH terms:
|
Cystic Fibrosis Fibrosis Pancreatic Diseases Digestive System Diseases Lung Diseases |
Respiratory Tract Diseases Genetic Diseases, Inborn Infant, Newborn, Diseases Pathologic Processes |
ClinicalTrials.gov processed this record on May 23, 2013